Poly Medicure's Q3 FY 2025-26 Quarterly Results
- 06 Feb 2026
Result Summary
- Poly Medicure Ltd reported a 8.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.6%.
- Its expenses for the quarter were up by 16.8% QoQ and 24.7% YoY.
- The net profit decreased 22.9% QoQ and decreased 16.9% YoY.
- The earnings per share (EPS) of Poly Medicure Ltd stood at 6.99 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 519.92 | 477.83 | 446.01 | 8.8% | 16.6% |
Total Expenses | 417.19 | 357.10 | 334.51 | 16.8% | 24.7% |
Profit Before Tax | 95.93 | 120.73 | 111.51 | -20.5% | -14.0% |
Tax | 26.80 | 29.89 | 28.00 | -10.3% | -4.3% |
Profit After Tax | 70.81 | 91.80 | 85.23 | -22.9% | -16.9% |
Earnings Per Share | 6.99 | 9.06 | 8.48 | -22.8% | -17.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Poly Medicure Ltd is a prominent player in the healthcare industry, primarily engaged in the manufacturing and sale of medical devices and disposables. The company offers a diverse range of products including infusion therapy, central venous access catheters, blood management systems, anesthesia, and surgery devices. Poly Medicure Ltd is known for its extensive distribution network and commitment to quality, catering to both domestic and international markets. While specific recent developments are not available in this context, the company is generally recognized for its focus on innovation and expanding its product portfolio to meet the increasing demand in the medical sector.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Poly Medicure Ltd reported a total income of ₹519.92 crores. This represents an increase of 8.8% compared to the previous quarter (Q2FY26), where the total income was ₹477.83 crores. On a year-over-year basis, the company's revenue increased by 16.6% from ₹446.01 crores in Q3FY25. This growth in revenue highlights the company's ability to enhance its income streams over both the quarter and the year. The revenue performance reflects the company's ongoing efforts to expand its market presence and capitalize on its product offerings.
Profitability
During Q3FY26, Poly Medicure Ltd recorded a profit before tax of ₹95.93 crores, which is a decrease of 20.5% from ₹120.73 crores in the previous quarter (Q2FY26) and a 14.0% decrease from ₹111.51 crores in Q3FY25. The profit after tax for Q3FY26 amounted to ₹70.81 crores, marking a decline of 22.9% from ₹91.80 crores in Q2FY26 and a 16.9% decrease from ₹85.23 crores in Q3FY25. Earnings per share (EPS) also decreased to ₹6.99 in Q3FY26, down from ₹9.06 in Q2FY26 and ₹8.48 in Q3FY25. These figures indicate a contraction in profitability over both the quarter and the year.
Operating Metrics
In Q3FY26, Poly Medicure Ltd incurred total expenses of ₹417.19 crores, which represents a 16.8% increase from ₹357.10 crores in Q2FY26 and a 24.7% increase from ₹334.51 crores in Q3FY25. The tax expenses for the quarter were ₹26.80 crores, reflecting a decrease of 10.3% from ₹29.89 crores in Q2FY26 and a 4.3% decrease from ₹28.00 crores in Q3FY25. The company's operating metrics showcase an increase in expenses, which have impacted the overall profitability despite the growth in revenue. The analysis of these metrics provides insight into the company's operational efficiency and financial management over the reviewed periods.